Carbidopa, Levodopa And Entacapone
Product Images NDC 47335-001

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Carbidopa, Levodopa And Entacapone (NDC 47335-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa-chem-str (Carbidopa Chem Str)

Chemical structure diagram depicting the molecular structure of an active ingredient associated with Carbidopa, levodopa and entacapone, showing functional groups including hydroxyl, ketone and hydrazine moieties, as well as a water molecule (H2O) indicating it is a hydrate form.*

FDA Label Image

Entacapone-chem-str (Entacapone Chem Str)

Chemical structure diagram of the active ingredient from the product Carbidopa, levodopa and entacapone, showing the molecular arrangement of atoms and bonds in the compound.*

FDA Label Image

Levodopa-chem-str (Levodopa Chem Str)

Chemical structure of the active ingredient levodopa, showing its molecular composition including a benzene ring with two hydroxyl groups, an amine group, and a carboxylic acid group.*

FDA Label Image

Spl-carton1 (Spl Carton1)

Packaging label for Carbidopa, Levodopa and Entacapone Tablets, 12.5 mg/50 mg/200 mg, distributed by Sun Pharmaceutical Industries, Inc. The label states the NDC number 47335-001-88 and indicates a package size of 100 tablets. It includes manufacturing details from Orion Corporation, Finland, storage instructions, and a warning for healthcare providers about not combining lower strength tablets to avoid overdose risk. Barcodes are also visible on the label.*

FDA Label Image

Spl-carton2 (Spl Carton2)

Packaging label for Carbidopa, Levodopa and Entacapone Tablets, 18.75 mg/75 mg/200 mg, by Sun Pharmaceutical Industries, Inc. The label includes dosage instructions to swallow whole and storage conditions at 25°C, with excursions allowed between 15-30°C. It states the product is made in Finland by Orion Corporation and distributed by Sun Pharmaceutical Industries, Inc. The label also lists the active ingredient strengths per tablet and includes the NDC 47335-002-88 barcode.*

FDA Label Image

Spl-carton3 (Spl Carton3)

Carton label for Carbidopa, Levodopa and Entacapone Tablets 25 mg/100 mg/200 mg, distributed by Sun Pharmaceutical Industries, Inc. The label includes dosage instructions, storage conditions, and a listing of the active ingredients per tablet. Manufactured by Orion Corporation in Finland. The carton contains 100 tablets and highlights a warning for healthcare providers about combining tablet strengths.*

FDA Label Image

Spl-carton4 (Spl Carton4)

Packaging label for Carbidopa, Levodopa and Entacapone Tablets 31.25 mg/125 mg/200 mg by Sun Pharmaceutical Industries, Inc. The label shows the tablet strengths and components, NDC 47335-004-88, manufacturer Orion Corporation in Finland, and distributor Sun Pharmaceutical Industries, Inc. It includes storage instructions, dispensing guidelines, and a barcode.*

FDA Label Image

Spl-carton5 (Spl Carton5)

Packaging label for Carbidopa, Levodopa, and Entacapone Tablets, 37.5 mg / 150 mg / 200 mg, distributed by Sun Pharmaceutical Industries, Inc. The label includes dosage instructions, storage conditions, and manufacturer details (Orion Corporation, Finland). The package contains 100 tablets with a barcode and an NDC number 47335-005-88.*

FDA Label Image

Spl-carton6 (Spl Carton6)

Packaging label for Carbidopa, Levodopa, and Entacapone Tablets 50 mg/200 mg/200 mg by Sun Pharmaceutical Industries, Inc. The label indicates the tablets are film-coated, with specified strengths for each active ingredient. It includes storage instructions, dosage warnings, and manufacturer details from Orion Corporation in Finland. The package contains 100 tablets with NDC 47335-006-88.*

FDA Label Image

Spl-label1 (Spl Label1)

Label for Carbidopa, Levodopa and Entacapone Tablets by Sun Pharmaceutical Industries, Inc. The label lists active ingredients per tablet: Carbidopa 12.5 mg, Levodopa 50 mg, and Entacapone 200 mg. The product is manufactured by Orion Pharma in Finland and distributed by Sun Pharmaceutical in New Jersey. It includes storage instructions and a barcode.*

FDA Label Image

Spl-label2 (Spl Label2)

Label for Carbidopa, Levodopa and Entacapone Tablets by Sun Pharmaceutical Industries, Inc. Each film-coated tablet contains 18.75 mg Carbidopa USP, 75 mg Levodopa USP, and 200 mg Entacapone. The label indicates a 100 count package, manufactured by Orion Corporation in Finland and distributed by Sun Pharmaceutical Industries, Cranbury, NJ. Storage at 25°C with permitted excursions and instructions to swallow whole without crushing or chewing are also provided.*

FDA Label Image

Spl-label3 (Spl Label3)

Carbidopa, Levodopa and Entacapone Tablets label by Sun Pharmaceutical Industries, Inc. The label indicates each film-coated tablet contains 25 mg Carbidopa USP, 100 mg Levodopa USP, and 200 mg Entacapone. The package contains 100 tablets. Storage instructions and warnings are provided, including dosage guidance, temperature recommendations, and a caution against combining lower strength tablets to avoid entacapone overdose risk. The product is made in Finland by Orion Corporation and distributed by Sun Pharmaceutical Industries, Cranbury, NJ. The label features a barcode and the Sun Pharma logo.*

FDA Label Image

Spl-label4 (Spl Label4)

Label for Carbidopa, Levodopa and Entacapone Tablets containing 31.25 mg Carbidopa USP, 125 mg Levodopa USP, and 200 mg Entacapone per tablet. The package holds 100 tablets. Manufactured by Orion Corporation, Finland, and distributed by Sun Pharmaceutical Industries, Inc. The label includes storage instructions, dosage warnings, and a barcode.*

FDA Label Image

Spl-label5 (Spl Label5)

Label for Carbidopa, Levodopa and Entacapone Tablets showing active ingredients per film-coated tablet: Carbidopa USP 37.5 mg, Levodopa USP 150 mg, and Entacapone 200 mg. The label indicates 100 tablets per container, manufactured by Orion Corporation and distributed by Sun Pharmaceutical Industries, Inc. Additional handling and storage instructions are provided, including dosage directions and temperature storage range.*

FDA Label Image

Spl-label6 (Spl Label6)

Label for Carbidopa, Levodopa and Entacapone Tablets from Sun Pharmaceutical Industries, Inc. Each film-coated tablet contains 50 mg Carbidopa USP, 200 mg Levodopa USP, and 200 mg Entacapone. The package contains 100 tablets. The label includes storage instructions, dosage directions to swallow whole, and manufacturer details indicating the product is made in Finland and distributed by Sun Pharmaceutical in New Jersey.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.